Targeted News Service

FDA Center for Drug Evaluation & Research Issues Warning Letter to Pure Indulgence Aesthetics
April 10, 2026

WASHINGTON, April 10 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Pure Indulgence Aesthetics from its Center for Drug Evaluation and Research:

* * *

Recipient: Bridget M. Goddard, Manager, Pure Indulgence Aesthetics, 1695 East Southlake Boulevard Suite 150, Southlake, TX 76092, United States, info@pureindulgenceaesthetics.com

Issuing Office: Center for Drug Evaluation and Research (C . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form